104 related articles for article (PubMed ID: 37076992)
1. USP33 enhances cell survival and stemness by deubiquitinating CTNNB1 in BXPC-3 and SW1990 cells.
Zhong B; Zhu Q; Wang L; Wang F; Zheng Y; Lin S; Cheng X
Cell Biol Int; 2023 Aug; 47(8):1368-1380. PubMed ID: 37076992
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of USP33 in advanced colorectal cancer patients: new insights into β-arrestin-dependent ERK signaling.
Liu H; Zhang Q; Li K; Gong Z; Liu Z; Xu Y; Swaney MH; Xiao K; Chen Y
Oncotarget; 2016 Dec; 7(49):81223-81240. PubMed ID: 27835898
[TBL] [Abstract][Full Text] [Related]
3. USP33 promotes pancreatic cancer malignant phenotype through the regulation of TGFBR2/TGFβ signaling pathway.
Liu X; Xu J; Shen B; Xu J; Jiang J
Cell Death Dis; 2023 Jun; 14(6):362. PubMed ID: 37322017
[TBL] [Abstract][Full Text] [Related]
4. Reduced Expression of Deubiquitinase USP33 Is Associated with Tumor Progression and Poor Prognosis of Gastric Adenocarcinoma.
Chen Y; Pang X; Ji L; Sun Y; Ji Y
Med Sci Monit; 2018 May; 24():3496-3505. PubMed ID: 29802710
[TBL] [Abstract][Full Text] [Related]
5. USP33 regulates c-Met expression by deubiquitinating SP1 to facilitate metastasis in hepatocellular carcinoma.
Gan Q; Shao J; Cao Y; Lei J; Xie P; Ge J; Hu G
Life Sci; 2020 Nov; 261():118316. PubMed ID: 32835698
[TBL] [Abstract][Full Text] [Related]
6. Degradation of the deubiquitinating enzyme USP33 is mediated by p97 and the ubiquitin ligase HERC2.
Chan NC; den Besten W; Sweredoski MJ; Hess S; Deshaies RJ; Chan DC
J Biol Chem; 2014 Jul; 289(28):19789-98. PubMed ID: 24855649
[TBL] [Abstract][Full Text] [Related]
7. Deubiquitinase USP33 is negatively regulated by β-TrCP through ubiquitin-dependent proteolysis.
Cheng Q; Yuan Y; Li L; Guo T; Miao Y; Ren Y; Liu J; Feng Q; Wang X; Zhao P; Zuo Y; Qian L; Zhang L; Zheng H
Exp Cell Res; 2017 Jul; 356(1):1-7. PubMed ID: 28506875
[TBL] [Abstract][Full Text] [Related]
8. USP33 deubiquitinates and stabilizes HIF-2alpha to promote hypoxia response in glioma stem cells.
Zhang A; Huang Z; Tao W; Zhai K; Wu Q; Rich JN; Zhou W; Bao S
EMBO J; 2022 Apr; 41(7):e109187. PubMed ID: 35191554
[TBL] [Abstract][Full Text] [Related]
9. USP33 mediates Slit-Robo signaling in inhibiting colorectal cancer cell migration.
Huang Z; Wen P; Kong R; Cheng H; Zhang B; Quan C; Bian Z; Chen M; Zhang Z; Chen X; Du X; Liu J; Zhu L; Fushimi K; Hua D; Wu JY
Int J Cancer; 2015 Apr; 136(8):1792-802. PubMed ID: 25242263
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of USP22 reduces cell stemness and enhances the sensitivity of pancreatic cancer cells to cisplatin by inactivating the Wnt/β-catenin pathway.
Li Z; Huang X; Hu W; Lu H
Tissue Cell; 2022 Aug; 77():101787. PubMed ID: 35623308
[TBL] [Abstract][Full Text] [Related]
11. Deubiquitinating enzyme USP33/VDU1 is required for Slit signaling in inhibiting breast cancer cell migration.
Yuasa-Kawada J; Kinoshita-Kawada M; Rao Y; Wu JY
Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14530-5. PubMed ID: 19706539
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitin specific peptidase 33 promotes cell proliferation and reduces apoptosis through regulation of the SP1/PI3K/AKT pathway in retinoblastoma.
Wang H; Liu Z; Sun Z; Zhou D; Mao H; Deng G
Cell Cycle; 2021 Oct; 20(19):2066-2076. PubMed ID: 34470581
[TBL] [Abstract][Full Text] [Related]
13. USP33 deubiquitinates PRKN/parkin and antagonizes its role in mitophagy.
Niu K; Fang H; Chen Z; Zhu Y; Tan Q; Wei D; Li Y; Balajee AS; Zhao Y
Autophagy; 2020 Apr; 16(4):724-734. PubMed ID: 31432739
[TBL] [Abstract][Full Text] [Related]
14. USP33, a new player in lung cancer, mediates Slit-Robo signaling.
Wen P; Kong R; Liu J; Zhu L; Chen X; Li X; Nie Y; Wu K; Wu JY
Protein Cell; 2014 Sep; 5(9):704-13. PubMed ID: 24981056
[TBL] [Abstract][Full Text] [Related]
15. USP33 is a Biomarker of Disease Recurrence in Papillary Thyroid Carcinoma.
Jia M; Guo Y; Lu X
Cell Physiol Biochem; 2018; 45(5):2044-2053. PubMed ID: 29533940
[TBL] [Abstract][Full Text] [Related]
16. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
Ma X; Wang B; Wang X; Luo Y; Fan W
PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
[TBL] [Abstract][Full Text] [Related]
17. SNORD89 promotes stemness phenotype of ovarian cancer cells by regulating Notch1-c-Myc pathway.
Zhu W; Niu J; He M; Zhang L; Lv X; Liu F; Jiang L; Zhang J; Yu Z; Zhao L; Bi J; Yan Y; Wei Q; Huo H; Fan Y; Chen Y; Ding J; Wei M
J Transl Med; 2019 Aug; 17(1):259. PubMed ID: 31395064
[TBL] [Abstract][Full Text] [Related]
18. CircAGFG1 drives metastasis and stemness in colorectal cancer by modulating YY1/CTNNB1.
Zhang L; Dong X; Yan B; Yu W; Shan L
Cell Death Dis; 2020 Jul; 11(7):542. PubMed ID: 32681092
[TBL] [Abstract][Full Text] [Related]
19. USP33 regulates centrosome biogenesis via deubiquitination of the centriolar protein CP110.
Li J; D'Angiolella V; Seeley ES; Kim S; Kobayashi T; Fu W; Campos EI; Pagano M; Dynlacht BD
Nature; 2013 Mar; 495(7440):255-9. PubMed ID: 23486064
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of CENPU inhibits cervical cancer cell migration and stemness through the FOXM1/Wnt/β-catenin pathway.
Zhang X; Wang M; Zhang Y; Yang J; Duan W
Tissue Cell; 2023 Apr; 81():102009. PubMed ID: 36608638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
